Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Androic, Ilija ^b   Krämer, Andrea ^a   Yan, Ruilan ^c   Rödel, Franz ^a   Gätje, Regine ^a   Kaufmann, Manfred ^a   Strebhardt, Klaus ^a   Yuan, Juping ^a  

^a GOETHE UNIVERSITY   (Germany)

^b SANOFI   (France)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; PACLITAXEL; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT; CYCLIN B; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TUMOR GROWTH; UTERINE CERVIX CANCER; ANIMAL; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B; DOWN-REGULATION; FEMALE; HELA CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; PACLITAXEL; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR STEM CELL ASSAY; UTERINE CERVICAL NEOPLASMS;

EID: 60549107035     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-391     Document Type: Article

References (38)

1. Weigelt B Peterse JL 't Veer LJ Breast cancer metastasis: Markers and models Nat Rev Cancer 2005, 5:591-602 10.1038/nrc1670 16056258
2. Schiffman M Castle PE Jeronimo J Rodriguez AC Wacholder S Human papillomavirus and cervical cancer Lancet 2007, 370:890-907 10.1016/ S0140-6736(07)61416-0 17826171
3. Wang A Yoshimi N Ino N Tanaka T Mori H Overexpression of cyclin B1 in human colorectal cancers J Cancer Res Clin Oncol 1997, 123:124-127 10.1007/BF01269891: 9030252
4. Zhao M Kim YT Yoon BS Kim SW Kang MH Kim SH Kim JH Kim JW Park YW Expression profiling of cyclin B1 and D1 in cervical carcinoma Exp Oncol 2006, 28:44-48 16614707
5. Kawamoto H Koizumi H Uchikoshi T Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses Am J Pathol 1997, 150:15-23 1858517 9006317
6. Soria JC Jang SJ Khuri FR Hassan K Liu D Hong WK Mao L Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication Cancer Res 2000, 60:4000-4004 10945597
7. Banerjee SK Weston AP Zoubine MN Campbell DR Cherian R Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma: Relationship to cell death, proliferation, and transformation Am J Pathol 2000, 156:217-225 1868611 10623670
8. Hassan KA Ang KK El Naggar AK Story MD Lee JI Liu D Hong WK Mao L Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma Cancer Res 2002, 62:6414-6417 12438226
9. Rudolph P Kuhling H Alm P Ferno M Baldetorp B Olsson H Parwaresch R Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer Int J Cancer 2003, 105:674-680 10.1002/ijc.11132 12740917
10. Nozoe T Korenaga D Kabashima A Ohga T Saeki H Sugimachi K Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus Clin Cancer Res 2002, 8:817-822 11895914
11. Suzuki T Urano T Miki Y Moriya T Akahira J Ishida T Horie K Inoue S Sasano H Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor Cancer Sci 2007, 98:644-651 10.1111/ j.1349-7006.2007.00444.x 17359284
12. Egloff AM Vella LA Finn OJ Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer Cancer Res 2006, 66:6-9 10.1158/0008-5472.CAN-05-3389 16397206
13. Suzuki H Graziano DF McKolanis J Finn OJ T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease Clin Cancer Res 2005, 11:1521-1526 10.1158/1078-0432.CCR-04-0538 15746055
14. Innocente SA Abrahamson JL Cogswell JP Lee JM p53 regulates a G2 checkpoint through cyclin B1 Proc Natl Acad Sci USA 1999, 96:2147-2152 26751 10051609 10.1073/pnas.96.5.2147
15. Passalaris TM Benanti JA Gewin L Kiyono T Galloway DA The G(2) checkpoint is maintained by redundant pathways Mol Cell Biol 1999, 19:5872-5881 84436 10454534
16. Taylor WR DePrimo SE Agarwal A Agarwal ML Schonthal AH Katula KS Stark GR Mechanisms of G2 arrest in response to overexpression of p53 Mol Biol Cell 1999, 10:3607-3622 25646 10564259
17. MacLachlan TK Dash BC Dicker DT El Deiry WS Repression of BRCA1 through a feedback loop involving p53 J Biol Chem 2000, 275:31869-31875 10.1074/ jbc.M003338200 10884389
18. Yin XY Grove L Datta NS Katula K Long MW Prochownik EV Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression Cancer Res 2001, 61:6487-6493 11522645
19. Zoubine MN Weston AP Johnson DC Campbell DR Banerjee SK 2-methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression Int J Oncol 1999, 15:639-646 10493943
20. Perks CM Gill ZP Newcomb PV Holly JM Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines Br J Cancer 1999, 79:701-706 10.1038/sj.bjc.6690113 10070857
21. Schroeder MD Symowicz J Schuler LA PRL modulates cell cycle regulators in mammary tumor epithelial cells Mol Endocrinol 2002, 16:45-57 10.1210/ me.16.1.45 11773438
22. Cho NH Kang S Hong S An HJ Choi YH Jeong GB Choi HK Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection Cancer Lett 2006, 232;170-178 10.1016/ j.canlet.2005.02.026 16458113
23. Shen M Feng Y Gao C Tao D Hu J Reed E Li QQ Gong J Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis Cancer Res 2004, 64:1607-1610 10.1158/ 0008-5472.CAN-03-3321 14996718
24. Collecchi P Santoni T Gnesi E Giuseppe NA Passoni A Rocchetta M Danesi R Bevilacqua G Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas Cytometry 2000, 42:254-260 10.1002/ 1097-0320(20000815)42:4<254::AID-CYTO6>3.0.CO;2-S 10934345
25. Jin P Hardy S Morgan DO Nuclear localization of cyclin B1 controls mitotic entry after DNA damage J Cell Biol 1998, 141:875-885 2132764 9585407 10.1083/jcb.141.4.875
26. Park M Chae HD Yun J Jung M Kim YS Kim SH Han MH Shin DY Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest Cancer Res 2000, 60:542-545 10676633
27. Yuan J Yan R Kramer A Eckerdt F Roller M Kaufmann M Strebhardt K Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells Oncogene 2004, 23:5843-5852 10.1038/sj.onc.1207757 15208674
28. Yuan J Kramer A Matthess Y Yan R Spankuch B Gatje R Knecht R Kaufmann M Strebhardt K Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo Oncogene 2006, 25:1753-1762 10.1038/sj.onc.1209202 16278675
29. Yuan J Eckerdt F Bereiter-Hahn J Kurunci-Csacsko E Kaufmann M Strebhardt K Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 Oncogene 2002, 21:8282-8292 10.1038/sj.onc.1206011 12447691
30. Lacroix M Leclercq G Relevance of breast cancer cell lines as models for breast tumours: An update Breast Cancer Res Treat 2004, 83:249-289 10.1023/B:BREA.0000014042.54925.cc 14758095
31. Hernandez-Vargas H Palacios J Moreno-Bueno G Telling cells how to die: docetaxel therapy in cancer cell lines Cell Cycle 2007, 6:780-783 17377494
32. Simstein R Burow M Parker A Weldon C Beckman B Apoptosis, chemoresistance, and breast cancer: Insights from the MCF-7 cell model system Exp Biol Med (Maywood) 2003, 228:995-1003 14530507
33. Santamaria D Barriere C Cerqueira A Hunt S Tardy C Newton K Caceres JF Dubus P Malumbres M Barbacid M Cdk1 is sufficient to drive the mammalian cell cycle Nature 2007, 448:811-815 10.1038/nature06046 17700700
34. Zhao M Kim YT Yoon BS Kim SW Kang MH Kim SH Kim JH Kim JW Park YW Expression profiling of cyclin B1 and D1 in cervical carcinoma Exp Oncol 2006, 28:44-48 16614707
35. Cho NH Kang S Hong S An HJ Choi YH Jeong GB Choi HK Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection Cancer Lett 2006, 232:170-178 10.1016/ j.canlet.2005.02.026 16458113
36. Faltus T Yuan J Zimmer B Kramer A Loibl S Kaufmann M Strebhardt K Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells Neoplasia 2004, 6:786-795 1531682 15720805 10.1593/neo.04313
37. Bumcrot D Manoharan M Koteliansky V Sah DW RNAi therapeutics: A potential new class of pharmaceutical drugs Nat Chem Biol 2006, 2:711-719 10.1038/nchembio839 17108989
38. Petri ET Errico A Escobedo L Hunt T Basavappa R The crystal structure of human cyclin B Cell Cycle 2007, 6:1342-1349 17495533